Citation Impact
Citing Papers
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
2011 Standout
IL-1 Blockade in Autoinflammatory Syndromes
2014
Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade
2005
Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade
2007
Effective treatment of severe COVID-19 patients with tocilizumab
2020 Standout
Recurrent BRAF mutations in Langerhans cell histiocytosis
2010 Standout
Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee
2020 Standout
Rituximab therapy for juvenile-onset systemic lupus erythematosus
2007
Histiocytic Disorders: Recent Insights into Pathophysiology and Practical Guidelines
2009
Engineering precision nanoparticles for drug delivery
2020 Standout
Natural History of Plasma Leakage in Dengue Hemorrhagic Fever
2007
The German etanercept registry for treatment of juvenile idiopathic arthritis
2004
Biologics in Pediatric Rheumatology: Quo Vadis?
2016
Medical Treatment of Juvenile Idiopathic Arthritis
2005
Clinical experience of IL-6 blockade in rheumatic diseases—Implications on IL-6 biology and disease pathogenesis
2014
Modern management of children with haemophagocytic lymphohistiocytosis
2003
Interleukin 6: from bench to bedside
2006
Worsening of Macrophage Activation Syndrome in a Patient with Adult Onset Still’s Disease after Initiation of Etanercept Therapy
2001
Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial
2008
Safety and efficacy of once weekly etanercept 0.8 mg/kg in a multicentre 12 week trial in active polyarticular course juvenile idiopathic arthritis
2009
Pachydermoperiostosis: an update
2005
Hemophagocytic lymphohistiocytosis in an adult kidney transplant recipient successfully treated by plasmapheresis
2017
Reduced perforin expression in systemic juvenile idiopathic arthritis is restored by autologous stem-cell transplantation
2003
Autoinflammatory Disease Reloaded: A Clinical Perspective
2010 Standout
Interleukin-10-Producing Plasmablasts Exert Regulatory Function in Autoimmune Inflammation
2014 StandoutNobel
Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy
2008 Standout
Pro-resolving lipid mediators are leads for resolution physiology
2014 StandoutNature
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
2019 Standout
Should Rituximab be Considered as the First-Choice Treatment for Severe Autoimmune Rheumatic Diseases?
2007
Long‐term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis
2009
Rituximab in autoimmune bullous diseases: mixed responses and adverse effects
2006
Natural killer cell dysfunction: A common pathway in systemic‐onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis?
2004
Juvenile idiopathic arthritis
2007 Standout
Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement
2005
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis
2019
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease
2020
IL‐6: Regulator of Treg/Th17 balance
2010 Standout
Immunogenic cell death in cancer and infectious disease
2016 Standout
Etanercept therapy for patients with psoriatic arthritis and concurrent hepatitis C virus infection: Report of 3 cases
2004
Risk of new-onset uveitis in patients with juvenile idiopathic arthritis treated with anti-TNFα agents
2006
HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
2006 Standout
Long‐term open‐label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular‐course juvenile rheumatoid arthritis
2005
Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients
2001
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
2014 Standout
Biologic Agents for the Treatment of Juvenile Rheumatoid Arthritis
2004
Delivery technologies for cancer immunotherapy
2019 Standout
Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
2005
Functions of natural killer cells
2008 Standout
The IL-1 family of cytokines and receptors in rheumatic diseases
2019
Sensors of the innate immune system: their link to rheumatic diseases
2010 StandoutNobel
Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations
2004
Rapid and Sustained Remission of Systemic Juvenile Idiopathic Arthritis-Associated Macrophage Activation Syndrome Through Treatment With Anakinra and Corticosteroids
2011
IL-6 in Inflammation, Immunity, and Disease
2014 Standout
Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France
2007
A role of PIEZO1 in iron metabolism in mice and humans
2021 StandoutNobel
Imaging characteristics of hemophagocytic lymphohistiocytosis
2003
Graves' Ophthalmopathy
2010 Standout
Familial Mediterranean fever and related periodic fever syndromes/autoinflammatory diseases
2011
Caspase Functions in Cell Death and Disease
2013 Standout
Iron oxide MR contrast agents for molecular and cellular imaging
2004 Standout
Etanercept (Enbrel)-Associated Inflammatory Eye Disease: Case Report and Review of the Literature
2006
TNFα blockade in human diseases: An overview of efficacy and safety
2007
Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry
2008
Systemic JIA: new developments in the understanding of the pathophysiology and therapy
2009
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study
2020 Standout
Use of adalimumab in patients with juvenile idiopathic arthritis refractory to etanercept and/or infliximab
2009
Cranio-osteoarthropathy in sibs
2007
Adalimumab in the therapy of uveitis in childhood
2006
Macrophage Activation Syndrome in the Acute Phase of Kawasaki Disease
2010
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
2020 Standout
B cell depletion therapy for 19 patients with refractory systemic lupus erythematosus
2007
Hidradenitis suppurativa
2020 Standout
Mechanisms and Functions of Inflammasomes
2014 Standout
Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders
2001
Clinical Remission in Patients with Systemic Juvenile Idiopathic Arthritis Treated with Anti-Tumor Necrosis Factor Agents
2009
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
2012
Cytokines in the pathogenesis of rheumatoid arthritis
2007 Standout
The Immunology of Macrophage Activation Syndrome
2019
New insights in systemic juvenile idiopathic arthritis--from pathophysiology to treatment
2007
Current management of juvenile idiopathic arthritis
2006
Biological Therapies of Immunologic Diseases
2017
Inflammasomes: mechanism of action, role in disease, and therapeutics
2015 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
A case of macrophage activation syndrome successfully treated with anakinra
2008
Biologics for the treatment of juvenile idiopathic arthritis: a systematic review and critical analysis of the evidence
2007
Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity
2004
Toll-Like Receptor Signaling Pathways
2014 Standout
Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register
2008
Perception of self: distinguishing autoimmunity from autoinflammation
2015
Dengue
2007 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Local Administration of Interleukin-1 Receptor Antagonist Improves Diabetic Wound Healing
2018
Current concepts in the diagnosis and management of cytokine release syndrome
2014 Standout
Targeting the interleukin‐6 receptor: A new treatment for systemic juvenile idiopathic arthritis?
2005
Immunological and Inflammatory Functions of the Interleukin-1 Family
2009 Standout
RNA recognition by human TLR8 can lead to autoimmune inflammation
2013
A systematic review of effectiveness and economic evaluation of new drug treatments for juvenile idiopathic arthritis: etanercept
2002
Pathogenesis of Macrophage Activation Syndrome and Potential for Cytokine- Directed Therapies
2014
Cytokine Storm
2020 Standout
Kawasaki Disease Complicated With Macrophage Activation Syndrome: A Systematic Review
2017
Computational Evolution of Threonine-Rich β-Hairpin Peptides Mimicking Specificity and Affinity of Antibodies
2019 StandoutNobel
Hemophagocytic syndromes
2007
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
2020 Standout
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Macrophage activation syndrome
2002
Control of foreign Ag‐specific Ab responses by Treg and Tfr
2020 StandoutNobel
A review of the current use of rituximab in autoimmune diseases
2008
TNF‐mediated inflammatory disease
2007 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis.
2005
Macrophage Accumulation Associated With Rat Cardiac Allograft Rejection Detected by Magnetic Resonance Imaging With Ultrasmall Superparamagnetic Iron Oxide Particles
2001
Hematological Problems in Pediatric Intensive Care
2013 Standout
Immunology of Acute and Chronic Wound Healing
2021 Standout
Works of Pascal Pillet being referenced
Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type
2003
Ostéoarthropathie hypertrophique primitive familiale et dermatite atopique (maladie de Currarino)
2002
PFAPA syndrome is not a sporadic disease
2010
Rituximab therapy for childhood-onset systemic lupus erythematosus
2006
A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
2010
Novel proteasome assembly chaperone mutations in PSMG2/PAC2 cause the autoinflammatory interferonopathy CANDLE/PRAAS4
2019
Abdominal ultrasound findings in children with hemophagocytic lymphohistiocytosis
1999
Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: Report of five cases
1996